Neurologix, Inc.

MeiraGTx hopes to take a gene therapy candidate for Parkinson’s disease into Phase III based on positive efficacy and safety data from a small Phase II study that showed significant improvement on a d

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent M&A activity – licensing and alliances are cover

When Shire PLC created Shire Regenerative Medicine Inc. around the purchase of Advanced BioHealing Inc. (ABH) in 2011, it became the first major pharmaceutical or device company in some time t

Neurologix Inc. filed for voluntary Chapter 7 bankruptcy protection in US Bankruptcy Court for the District of Delaware on 16 March to liquidate assets after it spent the past year looking for financi